SCHEMBL4763402

SCHEMBL4763402

C=CCN(CCCC=CC)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.47
PAX8 Q06710 1/20 0.47
ALDH1A1 P00352 4/20 0.39
HCAR2 Q8TDS4 1/20 0.39
TGM2 P21980 2/20 0.37
F13A1 P00488 1/20 0.37
TGM1 P22735 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
BCHE P06276 2/20 0.36
SIGMAR1 Q99720 1/20 0.36
MAPK1 P28482 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
TOP1 P11387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL504963 0.89 CCR6 (0.52) CCR6PAX8ALDH1A1HCAR2TGM2
SCHEMBL3186219 0.82 CCR6 (0.50) CCR6PAX8ALDH1A1HCAR2TGM2
SCHEMBL541750 0.82 HCAR2 (0.51) CCR6PAX8ALDH1A1HCAR2TGM2
SCHEMBL15001656 0.80 CCR6 (0.56) CCR6PAX8ALDH1A1HCAR2TGM2
SCHEMBL14630761 0.80 ALOX5 (0.47) CCR6PAX8ALDH1A1HCAR2L3MBTL1
SCHEMBL21573938 0.79 ALDH1A1 (0.47) CCR6PAX8ALDH1A1HCAR2L3MBTL1
SCHEMBL19339174 0.79 ALDH1A1 (0.50) CCR6PAX8ALDH1A1HCAR2L3MBTL1
SCHEMBL13817860 0.79 CCR6 (0.46) CCR6PAX8ALDH1A1HCAR2L3MBTL1
SCHEMBL4690235 0.78 HCAR2 (0.47) CCR6PAX8ALDH1A1HCAR2TGM2
SCHEMBL928852 0.77 ALDH1A1 (0.49) CCR6PAX8ALDH1A1HCAR2TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307203-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2005-08-17 EP claimed
EP-1307203-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-05-07 EP claimed
WO-2001070232-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-09-27 WO claimed
EP-1320370-A4 METHOD OF TREATMENT SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed
EP-1307203-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2005-08-17 EP disclosed
WO-2005013909-A2 NOVEL CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2005-02-17 WO disclosed
EP-1392657-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-03-10 EP disclosed
EP-1392657-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2004-03-03 EP disclosed
WO-2003053331-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-07-03 WO disclosed
EP-1320370-A1 METHOD OF TREATMENT SmithKline Beecham Corporation (US) 2003-06-25 EP disclosed
WO-2003045909-A2 METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF AZEPINES SMITHKLINE BEECHAM CORPORATION (US) 2003-06-05 WO disclosed
EP-1278502-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2003-05-21 EP disclosed
EP-1307203-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-05-07 EP disclosed
EP-1278502-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-01-29 EP disclosed
WO-2002017924-A1 METHOD OF TREATMENT SMITHKLINE BEECHAM CORPORATION (GB) 2002-03-07 WO disclosed
WO-2001089451-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-29 WO disclosed
WO-2001070232-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-09-27 WO disclosed